(Q34032743)

30 July 2017

1 reference

title

Obsessive-compulsive disorder in children (English)

1 reference

obsessive-compulsive disorder

30 July 2017

0 references

author name string

Piacentini J

series ordinal

1

1 reference

PubMed ID

10986725

30 July 2017

Bergman RL

series ordinal

2

1 reference

30 July 2017

1 September 2000

1 reference

Psychiatric Clinics of North America

30 July 2017

1 reference

30 July 2017

23

1 reference

30 July 2017

519-533

1 reference

30 July 2017

3

1 reference

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Neurobiology of childhood obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Pharmacotherapy in children and adolescents with obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

A pilot follow-up study of childhood soft signs and the development of adult psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Toward a neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Childhood rituals: normal development or obsessive-compulsive symptoms?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Case study: behavioral treatment of obsessive-compulsive disorder in a boy with comorbid disruptive behavior problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

The inheritance of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

A family study of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Cognitive behavioral therapy of childhood OCD.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Obsessive compulsive disorder in children and adolescents: phenomenology and family history

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Age differences in the reliability of parent and child reports of child anxious symptomatology using a structured interview.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

Frequency of obsessive-compulsive disorder in a community sample of young adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

The epidemiology of obsessive-compulsive disorder in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970178-7

7 January 2021

10.1016/S0193-953X(05)70178-7

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10986725